DDEL-08 OVERALL SAFETY AND EFFICACY IN SUBJECTS WITH RECURRENT HGG TREATED ACROSS 2 TOCAGEN STUDIES - PROGNOSTIC FACTORS ASSOCIATED WITH SURVIVAL

類似資料

• DDEL-06 PRELIMINARY SAFETY OF TOCA 511, A RETROVIRAL REPLICATING VECTOR, IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA ACROSS THREE SEPARATE PHASE 1 STUDIES
  著者:: Kalkanis, Steven N., 等
  出版事項: (2015)
• SURG-10 TRANSCRANIAL TOCA 511 FOLLOWED BY TOCA FC IN SUBJECTS WITH RECURRENT HIGH GRADE GLIOMA (HGG)
  著者:: Aghi, Manish, 等
  出版事項: (2015)
• DDEL-07 INTRAVENOUS TOCA 511 DELIVERY LEADS TO VIRAL DNA IN RESECTED HGG
  著者:: Cloughesy, Timothy, 等
  出版事項: (2015)
• SURG-09 RESULTS OF A DOSE ESCALATION TRIAL OF TOCA 511 WITH TOCA FC IN RECURRENT HGG UNDERGOING REPEAT RESECTION
  著者:: Vogelbaum, Michael A., 等
  出版事項: (2015)
• OS09.6 Long-term follow-up data from 126 patients with recurrent high grade glioma from three Phase 1 trials of Toca 511 and Toca FC: Update and justification for a Phase 2/3 trial
  著者:: Aghi, M., 等
  出版事項: (2017)